These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia. Huang Y; Zheng H; Zhu Y; Hong Y; Zha J; Lin Z; Li Z; Wang C; Fang Z; Yu X; Liu L; Xu B Front Immunol; 2023; 14():1139517. PubMed ID: 36960073 [TBL] [Abstract][Full Text] [Related]
3. CD8 Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624 [TBL] [Abstract][Full Text] [Related]
4. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia. Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594 [TBL] [Abstract][Full Text] [Related]
5. Lactate acid promotes PD-1 Zhang Y; Huang Y; Hong Y; Lin Z; Zha J; Zhu Y; Li Z; Wang C; Fang Z; Zhou Z; Peng Y; Yu X; Liu L; Xu B Int Immunopharmacol; 2024 Mar; 130():111765. PubMed ID: 38447414 [TBL] [Abstract][Full Text] [Related]
6. Increased frequency of TIGIT Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801 [TBL] [Abstract][Full Text] [Related]
7. Scrutinizing the Expression and Blockade of Inhibitory Molecules Expressed on T Cells from Acute Myeloid Leukemia Patients. Abdolmaleki M; Mojtabavi N; Zavvar M; Vaezi M; Noorbakhsh F; Nicknam MH Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):265-273. PubMed ID: 29908544 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of aberrant PD-1 expression for acute leukemia prognosis. Ruan Y; Wang J; Zhang Q; Wang H; Li C; Xu X; Zhai Z Eur J Med Res; 2023 Sep; 28(1):383. PubMed ID: 37759316 [TBL] [Abstract][Full Text] [Related]
9. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia. Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373 [TBL] [Abstract][Full Text] [Related]
10. A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia. Huang J; Tan J; Chen Y; Huang S; Xu L; Zhang Y; Lu Y; Yu Z; Chen S; Li Y J Leukoc Biol; 2019 Sep; 106(3):725-732. PubMed ID: 31136687 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia. Zhou Q; Munger ME; Veenstra RG; Weigel BJ; Hirashima M; Munn DH; Murphy WJ; Azuma M; Anderson AC; Kuchroo VK; Blazar BR Blood; 2011 Apr; 117(17):4501-10. PubMed ID: 21385853 [TBL] [Abstract][Full Text] [Related]
12. Higher PD-1 expression concurrent with exhausted CD8+ T cells in patients with Tan J; Chen S; Lu Y; Yao D; Xu L; Zhang Y; Yang L; Chen J; Lai J; Yu Z; Zhu K; Li Y Chin J Cancer Res; 2017 Oct; 29(5):463-470. PubMed ID: 29142466 [TBL] [Abstract][Full Text] [Related]
13. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. Knaus HA; Berglund S; Hackl H; Blackford AL; Zeidner JF; Montiel-Esparza R; Mukhopadhyay R; Vanura K; Blazar BR; Karp JE; Luznik L; Gojo I JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385732 [TBL] [Abstract][Full Text] [Related]
14. Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia. Peng Q; Huang R; Wang H; Xiao H; Wang Y; Zhai Z; Wang Z Cancer Immunol Immunother; 2023 Dec; 72(12):4399-4414. PubMed ID: 37932426 [TBL] [Abstract][Full Text] [Related]
15. Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia. Huang S; Zhao Y; Lai W; Tan J; Zheng X; Zha X; Li Y; Chen S Cancer Biol Ther; 2023 Dec; 24(1):2278229. PubMed ID: 37962843 [TBL] [Abstract][Full Text] [Related]
16. PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Zhu L; Zeng H; Schell TD; Zheng H Blood Cancer J; 2015 Jul; 5(7):e330. PubMed ID: 26230954 [TBL] [Abstract][Full Text] [Related]
18. TOX-expressing terminally exhausted tumor-infiltrating CD8 Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194 [TBL] [Abstract][Full Text] [Related]
19. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. Schnorfeil FM; Lichtenegger FS; Emmerig K; Schlueter M; Neitz JS; Draenert R; Hiddemann W; Subklewe M J Hematol Oncol; 2015 Jul; 8():93. PubMed ID: 26219463 [TBL] [Abstract][Full Text] [Related]
20. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients]. Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]